Cargando…

High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer

PURPOSE: To determine the effectiveness of salvage radiation therapy (RT) in patients with loco-regional recurrences (LRR) following initial complete resection of non-small cell lung cancer (NSCLC) and assess prognostic factors affecting survivals. MATERIALS AND METHODS: Between 1994 and 2007, 64 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Sun Hyun, Ahn, Yong Chan, Nam, Heerim, Park, Hee Chul, Pyo, Hong Ryull, Shim, Young Mog, Kim, Jhingook, Kim, Kwhanmien, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481375/ https://www.ncbi.nlm.nih.gov/pubmed/23074111 http://dx.doi.org/10.3349/ymj.2012.53.6.1120

Ejemplares similares

Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer
por: Lee, Kyung Hwa, et al.
Publicado: (2019)

Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor?
por: Oh, Dongryul, et al.
Publicado: (2012)

Preoperative Concurrent Radiochemotherapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer
por: Kang, Min Kyu, et al.
Publicado: (2006)

Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience
por: Park, Hyojung, et al.
Publicado: (2017)

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
por: Shin, Sumin, et al.
Publicado: (2020)

Pattern of Recurrence after Curative Resection of Local (Stage I and II) Non-Small Cell Lung Cancer: Difference According to the Histologic Type
por: Choi, Yong Soo, et al.
Publicado: (2004)

Surgical Resection of Recurrent Lung Cancer in Patients Following Curative Resection
por: Kim, Hyoung Soo, et al.
Publicado: (2006)

Surgical Treatment of Non-Small Cell Lung Cancer with Isolated Synchronous Brain Metastases
por: I, Hoseok, et al.
Publicado: (2006)

Radiofrequency Ablation to Treat Loco-Regional Recurrence of Well-Differentiated Thyroid Carcinoma
por: Lee, Sun Jin, et al.
Publicado: (2014)

Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion
por: Kim, Hakyoung, et al.
Publicado: (2018)

Predicting Recurrence Using the Clinical Factors of Patients with Non-small Cell Lung Cancer After Curative Resection
por: Lee, Hyun Joo, et al.
Publicado: (2009)

Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy
por: Lee, Soohyeon, et al.
Publicado: (2011)

Analysis of 1,067 Cases of Video-Assisted Thoracic Surgery Lobectomy
por: Choi, Min Suk, et al.
Publicado: (2011)

Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
por: Cho, Won Kyung, et al.
Publicado: (2016)

Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx
por: Nam, Heerim, et al.
Publicado: (2022)

En bloc Extended Total Thymectomy and Extrapleural Pneumonectomy in Masaoka stage IVA Thymomas
por: Yang, Hee Chul, et al.
Publicado: (2011)

FDG PET/CT and Mediastinal Nodal Metastasis Detection in Stage T1 Non-Small Cell Lung Cancer: Prognostic Implications
por: Shin, Kyung Min, et al.
Publicado: (2008)

Response Evaluation after Neoadjuvant Chemoradiation by Positron Emission Tomography-Computed Tomography for Esophageal Squamous Cell Carcinoma
por: Park, Joon Suk, et al.
Publicado: (2013)

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Kim, Hana, et al.
Publicado: (2023)

Surgical Treatment of Pulmonary Diseases Due to Nontuberculous Mycobacteria
por: Koh, Won-Jung, et al.
Publicado: (2008)

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
por: Kim, Youjin, et al.
Publicado: (2019)

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
por: Chong, Yousun, et al.
Publicado: (2014)

Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer
por: Shin, Sumin, et al.
Publicado: (2020)

A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma
por: Lim, Sung Hee, et al.
Publicado: (2017)

Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer
por: Lee, Hyebin, et al.
Publicado: (2016)

Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer
por: Shin, Hyunju, et al.
Publicado: (2021)

Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
por: Ahn, Stephen, et al.
Publicado: (2022)

Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
por: Sun, Jong-Mu, et al.
Publicado: (2013)

Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
por: Lee, Jiyun, et al.
Publicado: (2019)

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
por: Noh, Jae Myoung, et al.
Publicado: (2015)

Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors
por: Choi, Nayeon, et al.
Publicado: (2023)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Thymic Epithelial Tumors Classified According to a Newly Established WHO Scheme: CT and MR Findings
por: Han, Joungho, et al.
Publicado: (2003)

Clinical Value of Surveillance (18)F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy
por: Lim, Chae Hong, et al.
Publicado: (2022)

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma
por: Oh, Dongryul, et al.
Publicado: (2016)

Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial
por: Park, Geumju, et al.
Publicado: (2021)

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
por: Lee, Sangheun, et al.
Publicado: (2013)

The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer
por: Ahn, Myung-Ju, et al.
Publicado: (2012)

Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors
por: Kim, Hongsik, et al.
Publicado: (2021)

Prognosis After Surgical Resection of M1a/M1b Esophageal Squamous Cell Carcinoma
por: Shim, Young Mog, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_2pkqf6d3f1sc89lbsbhk2jekde